This policy statement identifies the potential value of electronic prescribing (e-prescribing) systems in improving quality and reducing harm in pediatric health care. On the basis of limited but positive pediatric data and on the basis of federal statutes that provide incentives for the use of e-prescribing systems, the American Academy of Pediatrics recommends the adoption of e-prescribing systems with pediatric functionality. The American Academy of Pediatrics also recommends a set of functions that technology vendors should provide when e-prescribing systems are used in environments in which children receive care. Pediatrics 2013;131:824-826
CONCLUSIONS E-prescribing systems can improve the quality and safety of medication administration by reducing preventable adverse drug events, 7-9 reducing dosing errors, 10 improving communication, 11, 12 avoiding adverse effects, 13, 14 and improving efficiency. 15 The benefits of eprescribing systems in pediatrics can only be achieved by systems with appropriate functionality and may be hampered by poorly developed systems 16 or implementation strategies. 17 At present, many e-prescribing systems fall short of providing expert-recommended functional characteristics. 18 Specific challenges in pediatric e-prescribing include age-and indication-specific, weight-based dosing requirements, rounding based on formulary (liquid or solid), the conversion of doses from an ingredient amount to a volume for liquids, the desire to provide easily administered home doses, and, when necessary, extemporaneously compounded dosage forms. Although these systems already confer numerous advantages over the paper-based alternative, they will need to evolve to be an ideal platform for safe and effective pediatric medication prescribing. The features listed in Table 1 , derived in part from previous work by the AAP, 19 will help address these challenges to safe and effective pediatric prescribing. The online version of this article, along with updated information and services, is 
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